Colorectal Cancer — 5-Minute Journal Club Issue 1 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Research To Practice | Oncology Videos · Dr. Neil Love
January 6, 202620m 48s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring an interview with Dr Scott Kopetz, including the following topics:
- Circulating tumor DNA (ctDNA)-based molecular residual disease (MRD) and survival among patients with resectable colorectal cancer (CRC) in the CIRCULATE-Japan GALAXY trial (0:00)
- ctDNA for detection of MRD in patients with CRC in the BESPOKE CRC and INTERCEPT trials (3:11)
- Clinical utility of including ctDNA monitoring in standard CRC surveillance (11:11)
- ctDNA analysis guiding adjuvant therapy for CRC in the DYNAMIC and CIRCULATE-North America trials (15:52)